Latest news

548529799 huge
02.06.21

ASCO Leadership Development Program Asia Pacific

NZSO health equity conference
02.06.21

Health equity virtual conference-be part of the solution!

NZSO Mel Net logo
02.06.21

Abstract Submissions for 2021 Melanoma Network of New Zealand Melanoma Summit

ASCO Leadership Development Program Asia Pacific

The ASCO Leadership Development Program for the Asia-Pacific region (LDP-AP) teaches culturally-relevant skills in leadership, advocacy, communication, presentation skills, media skills, and conflict management. Participants will be selected based on their commitment to improving cancer care and potential for leadership. At the conclusion of the program, participants will be better able to lead successful advocacy efforts, to build relationships with leaders within their countries, and to lead within their own societies, institutions, and ASCO.

Program Objective – Bring together a diverse pan-Asian interdisciplinary group of emerging leaders in oncology who are empowered to identify and fill leadership roles in oncology, to engage in advocacy efforts, and to promote interdisciplinary collaboration across the region and within ASCO.

Program Highlights Participants will learn skills through both virtual and in-person sessions. They will participate actively in small group discussions, small group projects, and a 2-3 day in person workshop.

To apply for the ASCO Leadership Development Program Asia Pacific, applicants must:

  • Be an ASCO Member (or submit a membership application in conjunction with the application)
  • Commit to participating in monthly virtual learning sessions, small group projects, and one in-person workshop to be held August 25-27 in Japan.
  • Meet English language fluency requirements

NOTE: The Leadership Development Program Asia Pacific includes mandatory participation in the in-person workshop to be held at the Breakthrough Meeting in Yokohama, Japan, August 25-27, 2022. Travel expenses for participants will be provided.

Key Dates

Online Application Open: May 18, 2021
Application Due: June 30, 2021
Notifications: September 10, 2021
Program Period: November 2021 - November 2022
In-person Seminar: August 25-27, 2022 (Breakthrough in Yokohama Japan)

If you have questions about the ASCO Leadership Development Program Asia Pacific, please email international@asco.org.

Health equity virtual conference-be part of the solution!

Registrations are open for the Creating Solutions-Towards better health equity for all Conference. The virtual conference is being held on 2-3 July and is being co-hosted by the Association of Salaried Medical Specialists and the Canterbury Charity Hospital Trust. There is an exciting programme of national and international speakers and health sector leaders. It is being opened by the Health Minister Andrew Little. All those attending will be asked to contribute to practical solutions to growing health inequities in Aotearoa New Zealand.

Some of the topics include:

  • How to address poverty in a low wage economy and high cost country
  • Ethnic and cultural prejudice: the long term effects of colonization
  • Universal free access to health care
  • How health workforces can encourage affirmative action

You can find out more and register here

Abstract Submissions for 2021 Melanoma Network of New Zealand Melanoma Summit Open

MelNet members are invited to submit abstracts on innovative initiatives, research projects and models of best practice for melanoma prevention, diagnosis, treatment or care in New Zealand.

Submissions close 5.00 pm Wednesday 30 June 2021.

Oral and Poster presentations types. Abstracts in by 30th June, Conference 10-12 September. For more information click here.

NZSO Mel Net logo

Clinical Research Fellow in Early Phase Cancer Trials

Department of Oncology, University of Oxford, Churchill Hospital, OXFORD, OX3 7LE, United Kingdom

The Department of Oncology has an opportunity for a Clinical Research Fellow to work on the Early Phase Cancer Trials Unit at the University of Oxford from January 2022 (start date can be negotiated). The post holder will be working alongside staff in the Oxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust and the University of Oxford. As part of the training programme the applicant will have the opportunity to undertake a clinical or translational research project at the Oxford Cancer Centre.

The Early Phase Cancer Trials Unit at the University of Oxford is a specialist, dedicated clinical trials unit, supporting early phase research integrating oncology and haematology as a seamless service. Recruiting over 150 patient per year, our key remit is the testing of novel therapies, on a bespoke 15 bedded ward incorporating a sample handling laboratory. Under the direction of our Principle Investigators, who are world-leading clinicians and clinician scientists, a team of research nurses and clinical fellows work across the broad portfolio of studies, providing expertise in patient management and protocol compliance.

The successful candidate will be a GMC registered Medical Practitioner (or eligible for GMC registration), with relevant and substantial hospital service, including experience of managing cancer patients, and to have held specialist training hospital appointments in oncology or surgery.

Closing date: 2nd July 2021

Advert here

2022 RACP Foundation Research Awards

Applications are now open for the RACP Foundation Research Awards, which provide research funding for 2022. Up to 50 awards up to a total value of $2.5 million and are available to RACP Fellows and trainees from Australia and Aotearoa New Zealand.

Funding is available in the following categories:

Applications for Education Development Grantsfor funding in 2021 and Research Development Scholarships and Travel Grants for funding in 2022 will open Monday, 1 June 2021.

Awards which may be of interest for your members include:

  • Arnott Research Entry Scholarship in Cancer Research
  • The Servier Staff "Barry Young" Research Establishment Fellowship
  • RACP GSK Research Establishment Fellowship

Full details for these opportunities including eligibility and application closing dates are available on the RACP Foundation Research Awards webpage.

Please forward this email to colleagues who may be interested in applying for these or the other awards available.

Should you have any questions, please email us.

Notice of discontinuation of CeeNU Australia and New Zealand

Bristol Myers Squibb would like to inform you that the sale and distribution of CeeNU (lomustine) will be discontinued in Australia and New Zealand in December 2022. This discontinuation includes all dose strengths (10mg and 40mg). The decision to discontinue CeeNU is due to declining demand and the availability of newer, preferred therapies (recommended by current treatment guidelines) for the treatment of brain tumours, such as glioblastomas. As such, the decision to discontinue CeeNU is voluntary and not related to any quality, safety or efficacy issues regarding the product.

NZSO Bristol meyers squibb

Welcome to the sixth issue of Skin Cancer Research Review.

This issue includes research reporting that patients who relapse after adjuvant targeted therapy for BRAFmutated stage III melanoma respond well to subsequent anti-PD-1-based therapy with outcomes similar to those seen with first-line anti-PD-1 therapy for stage IV melanoma. We have also included a long-term safety report from three of the KEYNOTE trials of pembrolizumab monotherapy for melanoma. Research conducted in participants from a dermoscopy masterclass found that the accuracy of diagnosing lentigo maligna improved after they were trained in the inverse approach, added to the classic pattern analysis. This issue concludes with an Australian study investigating discrepancies between biopsy results and final excised specimens in keratinocyte carcinomas.

We hope you enjoy the research selected, and we look forward to your comments and feedback.

Kind regards,
Dr Annie Wong

New Fellowship, Ngā Ahurei a Te Apārangi, and Honorary Fellowship, Ngā Ahurei Honore a Te Apārangi

The Academy of the Royal Society Te Apārangi is today calling for new Fellowship, Ngā Ahurei a Te Apārangi, and Honorary Fellowship, Ngā Ahurei Honore a Te Apārangi, nominations for 2021.

Fellowshipof the Royal Society of New Zealand is an honour proposed by one’s peers and conferred for distinction in research or the outcomes resulting from intellectual endeavour (Advancement).

A web portal has been set up to receive new and updated nominations, so please email (academy@royalsociety.org.nz) if you wish to submit a new nomination and you will be provided with a URL to access the web portal. Details of the nomination process and requirements can be found here, and the closing date is 30 June 2021.

Please note that the Academy is focused on increasing the diversity of nominations from under-represented groups, particularly with respect to gender, ethnicity, and employment context.

Nau mai, haere mai, welcome to ANZCCART 2021. 25th-27th July, Queenstown.

This year’s conference looks at ‘openness’ in animal research and teaching. Public confidence in animal research hinges on the scientific community engaging in the evolving conversation about how and why animals are used. Being open about these matters is a worthwhile endeavour, and to be encouraged.

To gain a broader perspective on how openness looks in practise, we will examine overseas examples, both success stories and failures, and learn from different cultural viewpoints.

We anticipate that the adoption of new approaches to openness will reflect constructively on ANZCCART‘s principal objectives, particularly the Three R’s – the refinement, reduction and replacement of animals in research and teaching.

The NZ Ministry of Education has released the draft content for each NCEA Level 1 subject:

  • Learning Matrices – a new product which identify and describe the significant learning of subjects that can be used to develop robust teaching and learning programmes.
  • Assessment Matrices – which identify the significant learning that will be assessed and credentialed at each NCEA level.
  • Course Outlines – which provide examples of how significant learning can inform a year of teaching and learning.
  • Initial draft Teaching, Learning and Assessment guides – which provide the overarching framework and structure to the assessment package, detailing links between The New Zealand Curriculum and the assessment at NCEA level.

Feedback can be provided through online questionnaires until 19 April 2021:

Questionnaire in English

Questionnaire in te reo Māori

Draft NCEA Level 1 achievement standards and assessment activities will be developed from May to August 2021, when feedback will be sought on this content.

More information is available on the NCEA Education website. If you have any queries in the meantime, please email us at ncea.review@education.govt.nz

Are you a doctor, nurse or allied healthcare professional working in Aotearoa?

We invite Maori and non-Maori healthcare professionals who have provided care for patients with cancer to take part in a brief online survey. iPad Mini up for grabs.

Click here to start the survey.

The call for nominations for medals and awards for the 2021 round is now open.

Please note that the Academy Executive Committee is focused on increasing the diversity of nominations from under-represented groups, particularly with respect to gender, ethnicity and employment context, from Crown Research Institutes and Independent Research organisations.

Podcast episode featuring Diana Safartis

Please see below the podcast episode featuring a really in-depth interview with Diana Safarti, discussing Global Disparity of Cancer Care and specifically in the Pacific. Here’s the link for you to listen: https://oncologynews.com.au/th...

To subscribe to Oncology News Australia, which includes a mix of conference coverage, reviews, news, opinion pieces, podcasts –https://us7.list-manage.com/su...

NZSO THE ONCOLOGY JOURNAL
NZSO Openness Agreement

Openness Agreement on the use of animals in research and teaching in New Zealand

Foreword from Professor Juliet Gerrard, The Prime Minister’s Chief Science Advisor:

Why the Openness Agreement was developed?

The Australia New Zealand Council for the Care of Animals in Research and Teaching (ANZCCART) is an independent body that was established to provide a focus for consideration of the scientific, ethical and social issues associated with the use of animals in research and teaching. After years of promoting openness in animal research, ANZCCART has taken the lead in developing this Agreement

Important research featured on Newshub

from our very own Executive Member, Associate Professor Logan Walker

Click here to see the importance of mandatory genetic screenings for women diagnosed with breast cancer.

NZSO Loganwalker news
NRHC Roslyn Kemp

Roslyn Kemp, NZSO's immediate past President, has been promoted as a professor at the University of Otago!

Congratulations from all of us at NZSO!

2021 New Zealand Annual Scientific Meeting

On behalf of the Royal Australian and New Zealand College of Radiologists (RANZCR) and the 2021 NZ ASM Organising Committee, we are happy to confirm

Friday 6 - Sunday 8 August 2021 | The InterContinental Hotel | Wellington, New Zealand

Given the continuing restrictions on international travel, our overseas speakers have confirmed that they will join us remotely – with pre-recorded presentations and then real-time participation with delegates for live Q & A:

Radiology

Professor Laurie A. Loevner, Chief, Division of Neuroradiology, Professor of Radiology, Neurosurgery, Otorhinolaryngology: Head & Neck Surgery and Ophthalmology, University of Pennsylvania Health System, USA.
Specialty Interests: Head and Neck, Neuroradiology

Associate Professor Bruno Giuffrè, University of Sydney at Northern Clinical School, Radiology Department, Royal North Shore Hospital, Sydney, Australia.
Specialty Interests: Musculoskeletal, RheumatologyAssociate

Radiation Oncology

Associate Professor Corrine Doll, Tom Baker Cancer Center, President of Canadian Association of Radiation Oncology, Calgary, Canada.
Specialty Interests: Gynecologic, Gastrointestinal Cancer Rheumatology

Registration and Abstract Submissions open on 8 April. For more information: www.ranzcr2021.co.nz.

NZSO RANZCR Illustrated Logo 01